Dr. Lal Pathlabs’ arm to acquire proprietorship concern

02 Apr 2019 Evaluate

Dr. Lal Pathlabs’ wholly owned subsidiary -- Pathlabs Unifiers has received an approval for acquisition of a Proprietorship Concern i.e. Bawankar Pathology. The Board of Directors of Pathlabs Unifiers at their meeting held on April 01, 2019, approved the same. 

Dr. Lal Pathlabs is recognized as a centre of innovation and a premier clinical pathology laboratory. It is the largest and most respected diagnostic service provider in the country. 

Dr. Lal Pathlabs Share Price

3025.95 -28.50 (-0.93%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7189.25
Max Healthcare Inst 1097.95
Narayana Hrudayalay 1916.45
Aster DM Healthcare 635.10
Global Health 1163.75
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×